Serial 76143646
Live / Registered — Registered and renewed (as of 25 Jul 2022)
What this means for you
Registered since 02 Jul 2002. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jul 2022).
Record
- Serial number
- 76143646
- Registration number
- 2589726
- Mark type
- Design / logo
- Filed
- 10 Oct 2000
- Published for opposition
- 17 Jul 2001
- Registered
- 02 Jul 2002
- Next maintenance due
- 02 Jul 2022
- Attorney of record
- B. Brett Heavner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceuticals for the treatment of autoimmune or inflammatory disorders
Owner
- SWEDISH ORPHAN BIOVITRUM AB (PUBL), Solna, SE
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 25 Jul 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 25 Jul 2022 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 25 Jul 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 25 Jul 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 Feb 2022 — TEAS SECTION 8 & 9 RECEIVED
- 02 Jul 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 24 Sept 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 05 Jul 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 05 Jul 2012 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 05 Jul 2012 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 05 Jul 2012 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Jun 2012 — TEAS SECTION 8 & 9 RECEIVED
- 21 Oct 2008 — NOTICE OF DESIGN SEARCH CODE MAILED
- 21 Apr 2008 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Apr 2008 — ASSIGNED TO PARALEGAL